Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases

Annals of Surgical Oncology

Volumn 8, Issue 4, 2001, Pages 347-353

  Adam, R ^a   Avisar, E ^a   Ariche, A ^a   Giachetti, S ^a   Azoulay, D ^a   Castaing, D ^a   Kunstlinger, F ^a   Levi, F ^a   Bismuth, F ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

Chronotherapy; Colorectal liver metastases; Neoadjuvant therapy; Nonresectable hepatic metastases

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER NODULE; LIVER RESECTION; MAJOR CLINICAL STUDY; POSTOPERATIVE COMPLICATION;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; SURVIVAL ANALYSIS;

EID: 0035018397     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.4.347     Document Type: Article

References (25)

1. Treatment of colorectal cancer hepatic metastasis
2. Resection of hepatic metastases from colorectal cancer: Biologic perspectives
3. Hematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
4. Multi-variate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer
5. Resection of hepatic metastases from colorectal cancer
6. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection
7. Resection of colorectal liver metastases
8. Liver resection for colorectal metastases
9. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
10. Resection of liver metastases. When is it worthwhile?
11. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants
12. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump
13. Right portal vein embolization in preparation for major hepatic resection
14. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
15. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors
16. Long term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
17. Oxaliplatin (L-OHP) as first line chemotherapy in metastatic colorectal cancer (MRC) patients: Preliminary activity/toxicity report
18. Chronomodulation of chemotherapy against metastatic colorectal cancer
19. A multicenter evaluation of intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin as initial treatment of patients with metastatic colorectal carcinoma
20. Bi weekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with metastatic colorectal cancer
21. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil and folinic acid (leucovorin) in patients with colorectal cancer metastases: A randomized multi-institutional trial
22. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
23. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma
24. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers